Muscle wasting and atrophy, not elsewhere classified

DOID EFO MESH Endpoint Browser PheWeb

M13_MUSCLEATROPH

muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.

Endpoint definition

↥

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 M62.5

Hospital discharge: ICD-9 7282A

Hospital discharge: ICD-8 7331

Cause of death: ICD-10 M62.5

Cause of death: ICD-9 7282A

Cause of death: ICD-8 7331

2 out of 7 registries used, show all original rules.

182

diagram downward connector

Check minimum number of events None

182

diagram downward connector

Include endpoints None

182

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

178

diagram downward connector

M13_MUSCLEATROPH

Control definitions

Control exclude M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 M62

Name in latin Atrophia et degeneratio musculi non alibi classificatae

NAME	M13_MUSCLEATROPH
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M625
HD_ICD_9	7282A
HD_ICD_8	7331
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M625
COD_ICD_9	7282A
COD_ICD_8	7331
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Muscle wasting and atrophy, not elsewhere classified based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	178	86	92
Unadjusted prevalence (%)	0.04	0.04	0.05
Mean age at first event (years)	55.73	51.63	59.56

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_MUSCLEATROPH – Muscle wasting and atrophy, not elsewhere classified
GWS hits:

Survival analyses between endpoints

↥

Plot

before Muscle wasting and atrophy, not elsewhere classified
after Muscle wasting and atrophy, not elsewhere classified

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Muscle wasting and atrophy, not elsewhere classified

↥

Endpoint not on priority list, no data to show.